Avsnitt
-
Moderator: Gail Kinman (London, UK)
Guest: Alice Accorroni (Geneva, Switzerland)
In this episode, Alice Accorroni speaks with Gail Kinman about burnout in healthcare and the role of occupational health psychology in its prevention and management. They discuss the definition and recognition of burnout, key warning signs, and the importance of organisational factors, workplace culture, and leadership in supporting clinician wellbeing and maintaining safe neurological practice.
-
Moderator: Cláudia Santos Silva (Lisbon, Portugal)
Guest: Andrea Calvo (Turin, Italy)
In this episode, Cláudia Santos Silva speaks with Andrea Calvo about the genetics of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). They discuss the shared genetic basis of these disorders, key disease-associated genes, and the role of genetic testing, counselling, and result interpretation in clinical practice, highlighting how genetic discoveries are advancing precision medicine and emerging gene-targeted therapies in ALS and FTD. -
Saknas det avsnitt?
-
Moderator: Raffaele Dubbioso (Naples, Italy)
Guest: Andrea Malaspina (London, UK) and Francesco Di Lorenzo (Rome, Italy)
In this episode, Raffaele Dubbioso speaks with Andrea Malaspina and Francesco Di Lorenzo about the growing role of neurofilaments as biomarkers in amyotrophic lateral sclerosis and frontotemporal dementia. They discuss the biological basis and clinical interpretation of neurofilament measurements, their diagnostic and prognostic value, and their emerging role in identifying pre-symptomatic disease, monitoring progression, and supporting clinical trials in neurological practice. -
Moderator: Elisa Canu (Milan, Italy)
Guest: Anna Gilioli (Milan, Italy)
In this episode, Elisa Canu speaks with Anna Gilioli about social cognition impairment in amyotrophic lateral sclerosis (ALS). They discuss its clinical manifestations, underlying neurobiological mechanisms, and assessment approaches, highlighting the importance of early recognition and its implications for patient management, prognosis, and multidisciplinary neurological care. -
Moderator: Valentina Iuzzolino (Naples, Italy)
Guest: Elka Stefanova (Belgrade, Serbia) and Mamede de Carvalho (Lisbon, Porugal)
In this episode, Valentina Iuzzolino speaks with Elka Stefanova and Mamede de Carvalho about diagnostic challenges in amyotrophic lateral sclerosis and frontotemporal dementia. They discuss clinical heterogeneity, key differential diagnoses and red flags, the role of Gold Coast criteria and neurophysiology in ALS, and the importance of longitudinal clinical assessment and neuroimaging in distinguishing frontotemporal dementia from primary psychiatric disorders. -
Moderator: Raphael Wurm (Vienna, Austria)
Guest: Roland Wiest (Bern, Switzerland)
In this episode, Raphael Wurm speaks with Roland Wiest about how the AI revolution is set to reshape the clinical environment in neurology. They discuss the areas where augmentation and automation are likely to have the greatest impact, including neuroimaging, clinical workflows, and decision support, while exploring how neurologists can prepare themselves and their institutions to translate emerging AI technologies into meaningful improvements for both clinicians and patients. -
Moderator: Georg Starke (Munich, Germany)
Guest: Giulia Di Rauso (New York, USA)
In this episode, Georg Starke speaks with Giulia Di Rauso about trustworthiness and the use of artificial intelligence in neurological research and clinical practice. They discuss explainability, data quality, interpretability, and human oversight in AI systems, highlighting key considerations for responsible integration of AI tools into neurology and the importance of maintaining clinical judgement. -
Moderator: Maria Chiara Malaguti (Rovereto, Italy)
Guest: Gary Leeming (Liverpool, UK)
In this episode, Maria Chiara Malaguti and Gary Leeming discuss the evolving role of artificial intelligence in neurology. Aimed at clinical neurologists, the conversation explores how AI may support clinical practice, while also addressing its limitations, ethical implications, and the need for human oversight. As AI becomes increasingly embedded in healthcare, neurologists will need to develop a solid understanding of these tools in order to use them critically, guide their implementation, and remain in control of clinical decision-making. -
Moderator: Raphael Bernard-Valnet (Lausanne, Switzerland)
Guest: Roland Wiest (Bern, Switzerland) and Monica Moroni (Trento, Italy)
In this episode, Raphael Bernard-Valnet speaks with Roland Wiest and Monica Moroni about the fundamentals of artificial intelligence in clinical neurology and its practical implications for neurologists. They discuss key applications such as imaging analysis, diagnostic and decision-support tools, and emerging use in wearables, while addressing interpretability, standardisation, and current barriers to routine clinical implementation. -
Moderator: Kirsten R. Müller-Vahl (Hanover, Germany)
Guest: Natalia Szejko (Warsaw, Poland) and Anna Dunalska (Warsaw, Poland)
In this episode, Kirsten R. Müller-Vahl speaks with Natalia Szejko and Anna Dunalska about functional neurological disorders and the influence of social media. They discuss common clinical presentations, challenges in diagnosis based on positive signs, and the impact of online information on symptom expression, patient expectations, and clinical management, with implications for contemporary neurological practice. -
Moderator: Selma Aybek (Fribourg, Switzerland)
Guests: Gabriela Gilmour (Calgary, Canada) and Katarzyna Śmiłowska (Sosnowiec, Poland)
In this episode, Selma Aybek speaks with Gabriela Gilmour and Katarzyna Śmiłowska about the overlap between functional neurological disorders and movement disorders. They discuss key diagnostic principles based on positive clinical signs, mechanisms underlying co-occurrence, and practical challenges in distinguishing functional symptoms from conditions such as Parkinson’s disease, with implications for accurate diagnosis and management in neurological practice. -
Moderator: Primavera Spagnolo (Boston, MA)
Guest: Natalia Szejko (Warsaw, Poland) and Anna Dunalska (Warsaw, Poland)
In this episode, Primavera Spagnolo speaks with Natalia Szejko and Anna Dunalska about functional neurological disorders, focusing on the influence of biological sex and gender on their development and clinical presentation. They discuss diagnostic features, epidemiology and female predominance, neurobiological and sociocultural factors, sex-related differences in presentation and comorbidities, and implications for sex- and gender-informed diagnosis and multidisciplinary care in neurological practice. -
Moderator: Veronica Cabreira (Porto, Portugal)
Guest: Mark Edwards (London, UK) and Jon Stone (Edinburgh, UK)
Functional Neurological Disorder (FND) remains one of the most common yet least adequately taught conditions in neurology training across Europe. In this episode, moderator Veronica Cabreira and expert guests Jon Stone and Mark Edwards reflect on historical and contemporary factors that contribute to major gaps in education and training on FND across Europe. They argue that FND should be the “business” of Neurologists and provide their insights into advocating for better clinical pathways and specialist services, integrating evidence-based FND teaching, and aligning health policy for FND with modern clinical practice. -
Moderator: Taras Voloshyn (Kyiv, Ukraine)
Guests: Laavanya Damodaran (Birmingham, UK), Osman Malik (London, UK)
In this episode, Taras Voloshyn speaks with Laavanya Damodaran and Osman Malik about autism spectrum disorder across the lifespan, with particular focus on the transition from childhood to adulthood. They discuss core diagnostic features, early clinical signs, evolving presentations in adult patients, and the challenges of recognition, comorbidities, and long-term multidisciplinary support in neurological and psychiatric practice. -
Moderator: Francesco Germano (Genoa, Italy)
Guest: Matteo Cataldi (Genoa, Italy)
In this episode, Francesco Germano speaks with Matteo Cataldi about Guillain-Barré syndrome and other inflammatory neuropathies across the lifespan. They discuss key age-related differences in epidemiology, clinical presentation, diagnostic challenges, and management strategies in pediatric and adult patients, highlighting practical considerations for early recognition, risk assessment, and treatment in neurological practice. -
Moderator: Natalia Szejko (Warsaw, Poland)
Guests: Tammy Hedderly (London, UK), Alexander Münchau (Lübeck, Germany)
In this episode, Natalia Szejko speaks with Tammy Hedderly and Alexander Münchau about the similarities and differences in movement disorders across the lifespan. They discuss the clinical evolution of tics and stereotypies from childhood to adulthood, the distinct diagnostic implications of dystonia and parkinsonism in pediatric versus adult populations, and the importance of multidisciplinary care and acceptance-based strategies in neurological practice. -
Moderator: Meagan Watson (Denver, USA)
Guests: Pavlina Danhofer (Brno, Czech Republic), Natalia Szejko (Warsaw, Poland)
In this episode, Meagan Watson speaks with Pavlína Danhofer and Natalia Szejko about whether functional neurological disorders (FNDs) present differently in children and adults. They discuss age-specific clinical features, comorbidities, developmental and family context, diagnostic challenges, and the role of early, tailored multidisciplinary management to improve outcomes in neurological practice. -
In this episode, Yıldız Değirmenci speaks with Julie Hall and Marit Ruitenberg about non-motor symptoms in Parkinson’s disease, focusing on anxiety and cognitive impairment. They examine their clinical profiles, early detection challenges including neuropsychological markers, interactions with motor manifestations, and implications for comprehensive assessment and individualized management in neurological practice.
-
Moderator: João Durães (Coimbra, Portugal)
Guests: Paola Giunti (London, UK), Lidia Sarro (Milan, Italy)
In this episode, João Durães, Paola Giunti and Lidia Sarro provide a rigorous examination of the diagnostic and therapeutic landscape of treatable ataxias, focusing on rare variants. The discussion first delineates autoimmune etiologies, such as anti-GAD, paraneoplastic, and gluten-related syndromes, before transitioning to a detailed review of acquired and genetic metabolic disorders, including vitamin deficiencies, NPC, Refsum disease, Glut1 deficiency, CTX, and Wilson’s disease among others. By highlighting critical clinical and paraclinical "red flags," the contributors offer a framework for accelerating differential diagnosis. The session concludes with an analysis of contemporary pharmacological advancements, notably the recent EMA approval for Friedreich’s Ataxia and the efficacy of repurposed drugs in treating genetic forms such as EA1/2 and SCA27B. -
Moderator: Olimpia Musumeci (Messina, Italy)
Guests: Antonio Toscano (Messina, Italy), Marianne De Visser (Amsterdam, Netherlands)
In this episode, Olimpia Musumeci speaks with Antonio Toscano and Marianne de Visser about hereditary, particularly metabolic, and acquired myopathies, especially idiopathic inflammatory myopathies amenable to treatment. They review advances in pathophysiology, diagnostic approaches and novel therapies, highlighting clinical red flags and strategies that have a significant impact on timely diagnosis and management in daily neurological practice. - Visa fler
